Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effect of dosing with flutucasone furoate in asthmatic
subjects aged 5-11 years of age. A randomized, two-way crossover, with placebo control, over
a 14 day treatment period, it will investigate safety, tolerability, pharmacokinetics and
serum cortisol levels.